Moreover, the Cox multivariate regression model indicated that FGF21 is an independent DFS biomarker not related with stage or Fuhrman nuclear grade, the two clinical prognostic biomarkers employed currently in ccRCC. Here, FGF21 is linked to nonpapillary renal cell carcinoma.